Tocilizumab in symptomatic calcium pyrophosphate deposition disease: a pilot study
- PMID: 32213498
- DOI: 10.1136/annrheumdis-2020-217188
Tocilizumab in symptomatic calcium pyrophosphate deposition disease: a pilot study
Keywords: DMARDs (biologic); arthritis; chondrocalcinosis; treatment.
Conflict of interest statement
Competing interests: None declared.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources